Drug discovery CRO Evotec SE announced has entered into a partnership with Inserm, Lille University Hospital and Inserm Transfert to screen new biomarkers and targets in obesity and metabolic diseases.
https://european-biotechnology.com/wp-content/uploads/2024/06/Evotec_HQ.jpeg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-05-31 06:03:002024-07-07 09:34:40Consortium led by Evotec enters obesity drug space